191 related articles for article (PubMed ID: 35451949)
41. Bioinformatics Identification of Anti-CRISPR Loci by Using Homology, Guilt-by-Association, and CRISPR Self-Targeting Spacer Approaches.
Yin Y; Yang B; Entwistle S
mSystems; 2019 Sep; 4(5):. PubMed ID: 31506266
[TBL] [Abstract][Full Text] [Related]
42. Discovery of a conjugative megaplasmid in Bifidobacterium breve.
Bottacini F; O'Connell Motherway M; Casey E; McDonnell B; Mahony J; Ventura M; van Sinderen D
Appl Environ Microbiol; 2015 Jan; 81(1):166-76. PubMed ID: 25326305
[TBL] [Abstract][Full Text] [Related]
43. Fragmentation of the CRISPR-Cas Type I-B signature protein Cas8b.
Richter H; Rompf J; Wiegel J; Rau K; Randau L
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt B):2993-3000. PubMed ID: 28238733
[TBL] [Abstract][Full Text] [Related]
44. Recombination between phages and CRISPR-cas loci facilitates horizontal gene transfer in staphylococci.
Varble A; Meaden S; Barrangou R; Westra ER; Marraffini LA
Nat Microbiol; 2019 Jun; 4(6):956-963. PubMed ID: 30886355
[TBL] [Abstract][Full Text] [Related]
45. CRISPER/Cas in Plant Natural Product Research: Therapeutics as Anticancer and other Drug Candidates and Recent Patents.
Dey A; Nandy S
Recent Pat Anticancer Drug Discov; 2021; 16(4):460-468. PubMed ID: 34911411
[TBL] [Abstract][Full Text] [Related]
46. Characterization of 67 Confirmed Clustered Regularly Interspaced Short Palindromic Repeats Loci in 52 Strains of
Wang Y; Mao T; Li Y; Xiao W; Liang X; Duan G; Yang H
Front Microbiol; 2021; 12():736565. PubMed ID: 34751223
[No Abstract] [Full Text] [Related]
47. Investigation into the prevalent CRISPR-Cas systems among the Aeromonas genus.
Baliga P; Shekar M; Tg P; Sk G
J Basic Microbiol; 2021 Oct; 61(10):874-882. PubMed ID: 34486151
[TBL] [Abstract][Full Text] [Related]
48. Characterization and applications of Type I CRISPR-Cas systems.
Hidalgo-Cantabrana C; Barrangou R
Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
[TBL] [Abstract][Full Text] [Related]
49. Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence.
Semenova E; Jore MM; Datsenko KA; Semenova A; Westra ER; Wanner B; van der Oost J; Brouns SJ; Severinov K
Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10098-103. PubMed ID: 21646539
[TBL] [Abstract][Full Text] [Related]
50. Programmable plasmid interference by the CRISPR-Cas system in Thermococcus kodakarensis.
Elmore JR; Yokooji Y; Sato T; Olson S; Glover CV; Graveley BR; Atomi H; Terns RM; Terns MP
RNA Biol; 2013 May; 10(5):828-40. PubMed ID: 23535213
[TBL] [Abstract][Full Text] [Related]
51. CRISPR-Cas systems in oral microbiome: From immune defense to physiological regulation.
Gong T; Zeng J; Tang B; Zhou X; Li Y
Mol Oral Microbiol; 2020 Apr; 35(2):41-48. PubMed ID: 31995666
[TBL] [Abstract][Full Text] [Related]
52. CRISPR-Cas: biology, mechanisms and relevance.
Hille F; Charpentier E
Philos Trans R Soc Lond B Biol Sci; 2016 Nov; 371(1707):. PubMed ID: 27672148
[TBL] [Abstract][Full Text] [Related]
53. Computational Detection of CRISPR/crRNA Targets.
Biswas A; Fineran PC; Brown CM
Methods Mol Biol; 2015; 1311():77-89. PubMed ID: 25981467
[TBL] [Abstract][Full Text] [Related]
54. Efficient engineering of a bacteriophage genome using the type I-E CRISPR-Cas system.
Kiro R; Shitrit D; Qimron U
RNA Biol; 2014; 11(1):42-4. PubMed ID: 24457913
[TBL] [Abstract][Full Text] [Related]
55. Composition and Diversity of CRISPR-Cas13a Systems in the Genus
Watanabe S; Cui B; Kiga K; Aiba Y; Tan XE; Sato'o Y; Kawauchi M; Boonsiri T; Thitiananpakorn K; Taki Y; Li FY; Azam AH; Nakada Y; Sasahara T; Cui L
Front Microbiol; 2019; 10():2838. PubMed ID: 31921024
[TBL] [Abstract][Full Text] [Related]
56. Genome editing by miniature CRISPR/Cas12f1 enzyme in Escherichia coli.
Okano K; Sato Y; Hizume T; Honda K
J Biosci Bioeng; 2021 Aug; 132(2):120-124. PubMed ID: 34023220
[TBL] [Abstract][Full Text] [Related]
57. CRISPR-Cas systems exploit viral DNA injection to establish and maintain adaptive immunity.
Modell JW; Jiang W; Marraffini LA
Nature; 2017 Apr; 544(7648):101-104. PubMed ID: 28355179
[TBL] [Abstract][Full Text] [Related]
58. Cas4 Facilitates PAM-Compatible Spacer Selection during CRISPR Adaptation.
Kieper SN; Almendros C; Behler J; McKenzie RE; Nobrega FL; Haagsma AC; Vink JNA; Hess WR; Brouns SJJ
Cell Rep; 2018 Mar; 22(13):3377-3384. PubMed ID: 29590607
[TBL] [Abstract][Full Text] [Related]
59. Methods for the Analysis and Characterization of Defense Mechanisms Against Horizontal Gene Transfer: CRISPR Systems.
Calvo-Villamañán A; Bernheim A; Bikard D
Methods Mol Biol; 2020; 2075():235-249. PubMed ID: 31584167
[TBL] [Abstract][Full Text] [Related]
60. Characterization and Exploitation of CRISPR Loci in
Hidalgo-Cantabrana C; Crawley AB; Sanchez B; Barrangou R
Front Microbiol; 2017; 8():1851. PubMed ID: 29033911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
